Mereo Biopharma Group Plc ADR (NASDAQ:MREO) price on Thursday, August 01, fall -0.50% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $4.04.
A look at the stock’s price movement, the level at last check in today’s session was $4.06. Turning to its 52-week performance, $4.50 and $1.07 were the 52-week high and 52-week low respectively. Overall, MREO moved 17.10% over the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mereo Biopharma Group Plc ADR’s market cap currently stands at around $566.68 million.
Turning to the stock’s technical picture we see that short term indicators suggest on average that MREO is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
MREO’s current price about 2.37% and 9.14% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 55.30, while 7-day volatility ratio is 7.91% and 6.59% in the 30-day chart. Further, Mereo Biopharma Group Plc ADR (MREO) has a beta value of 0.89, and an average true range (ATR) of 0.26.
If we refocus on Mereo Biopharma Group Plc ADR (NASDAQ:MREO), historical trading data shows that trading volumes averaged 1.08 million over the past 3 months. The company’s latest data on shares outstanding shows there are 140.27 million shares.
The 0.00% of Mereo Biopharma Group Plc ADR’s shares are in the hands of company insiders while institutional holders own 63.24% of the company’s shares. Current price change has pushed the stock 74.89% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MREO stock continues to rise going into the next quarter.
